» Articles » PMID: 34276555

Clinical Characteristics and Risk of Diabetic Complications in Data-Driven Clusters Among Type 2 Diabetes

Overview
Specialty Endocrinology
Date 2021 Jul 19
PMID 34276555
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to cluster newly diagnosed patients and patients with long-term diabetes and to explore the clinical characteristics, risk of diabetes complications, and medication treatment related to each cluster.

Research Design And Methods: K-means clustering analysis was performed on 1,060 Chinese patients with type 2 diabetes based on five variables (HbA1c, age at diagnosis, BMI, HOMA2-IR, and HOMA2-B). The clinical features, risk of diabetic complications, and the utilization of elven types of medications agents related to each cluster were evaluated with the chi-square test and the Tukey-Kramer method.

Results: Four replicable clusters were identified, severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild obesity-related diabetes (MOD), and mild age-related diabetes (MARD). In terms of clinical characteristics, there were significant differences in blood pressure, renal function, and lipids among clusters. Furthermore, individuals in SIRD had the highest prevalence of stages 2 and 3 chronic kidney disease (CKD) (57%) and diabetic peripheral neuropathy (DPN) (67%), while individuals in SIDD had the highest risk of diabetic retinopathy (32%), albuminuria (31%) and lower extremity arterial disease (LEAD) (13%). Additionally, the difference in medication treatment of clusters were observed in metformin (p = 0.012), α-glucosidase inhibitor (AGI) (p = 0.006), dipeptidyl peptidase 4 inhibitor (DPP-4) (p = 0.017), glucagon-like peptide-1 (GLP-1) (p <0.001), insulin (p <0.001), and statins (p = 0.006).

Conclusions: The newly diagnosed patients and patients with long-term diabetes can be consistently clustered into featured clusters. Each cluster had significantly different patient characteristics, risk of diabetic complications, and medication treatment.

Citing Articles

Differential risk of cardiovascular complications in patients with type-2 diabetes mellitus in Ghana: A hospital-based cross-sectional study.

Obirikorang C, Adu E, Afum-Adjei Awuah A, Darko S, Ghartey F, Ametepe S PLoS One. 2025; 20(2):e0302912.

PMID: 39913381 PMC: 11801548. DOI: 10.1371/journal.pone.0302912.


Risk Evaluation of Progression of Proteinuria and Renal Decline Based on a Novel Subgroup Classification in Chinese Patients with Type 2 Diabetes.

Wang K, Qian Q, Bian C, Sheng P, Zhu L, Teng S Diabetes Ther. 2024; 16(1):89-102.

PMID: 39556310 PMC: 11759728. DOI: 10.1007/s13300-024-01667-7.


Clinical application of cluster analysis in patients with newly diagnosed type 2 diabetes.

Wang Y, Chen H Hormones (Athens). 2024; .

PMID: 39230795 DOI: 10.1007/s42000-024-00593-4.


Clinical characteristics and complication risks in data-driven clusters among Chinese community diabetes populations.

Li B, Yang Z, Liu Y, Zhou X, Wang W, Gao Z J Diabetes. 2024; 16(8):e13596.

PMID: 39136497 PMC: 11320751. DOI: 10.1111/1753-0407.13596.


Etiologies underlying subtypes of long-standing type 2 diabetes.

Bayoumi R, Farooqi M, Alawadi F, Hassanein M, Osama A, Mukhopadhyay D PLoS One. 2024; 19(5):e0304036.

PMID: 38805513 PMC: 11132508. DOI: 10.1371/journal.pone.0304036.


References
1.
Silva K, Pinto C, Biswas S, de Faria J, de Faria J . Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension. Curr Eye Res. 2007; 32(6):533-41. DOI: 10.1080/02713680701435391. View

2.
Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865):813-20. DOI: 10.1038/414813a. View

3.
Dennis J, Shields B, Henley W, Jones A, Hattersley A . Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 2019; 7(6):442-451. PMC: 6520497. DOI: 10.1016/S2213-8587(19)30087-7. View

4.
Ogurtsova K, da Rocha Fernandes J, Huang Y, Linnenkamp U, Guariguata L, Cho N . IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40-50. DOI: 10.1016/j.diabres.2017.03.024. View

5.
Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View